The company's financial structure has weakened significantly, with total assets falling from $1.4 billion in 2025Q2 to $710.4 million by 2025Q4 following the total write-down of goodwill.
| Total Current Assets | 383.17M | 544.61M | 575.69M | 644.54M | 651.83M | 466.77M | 85.75K | 363.95K |
| Cash & Short-Term Investments | 316.18M | 290.15M | 236.46M | 214.43M | 279.45M | 224.78M | 80.01K | 363.95K |
| Cash Only | 307.63M | 252.52M | 205.01M | 174.14M | 240.69M | 224.78M | 80.01K | 363.95K |
| Short-Term Investments | 8.56M | 37.63M | 31.45M | 40.28M | 38.76M | 0 | 0 | 0 |
| Accounts Receivable | 62.11M | 248.85M | 333.22M | 317.17M | 344.81M | 228.23M | 0 | 0 |
| Days Sales Outstanding | 18.26 | 66.63 | 83.21 | 59.66 | 75.47 | 68.16 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 69.55M | 44.56K | 0 | 0 | 0 |
| Total Non-Current Assets | 327.2M | 860.48M | 869.54M | 847.65M | 436.39M | 345.12M | 403.74M | 2.16M |
| Property, Plant & Equipment | 16.94M | 6.82M | 14.32M | 21.8M | 1.67M | 1.36M | 0 | 0 |
| Fixed Asset Turnover | 73.31x | 199.77x | 102.09x | 89.00x | 996.04x | 900.52x | - | - |
| Goodwill | 0 | 182.65M | 182.06M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 405.23M | 411.24M | 587.95M | 327.59M | 331.73M | 0 | 0 |
| Long-Term Investments | 271.24M | 257.37M | 253.84M | 232.64M | 101.62M | 5M | 403.74M | 0 |
| Other Non-Current Assets | 1.74M | 905.04K | 722.58K | 945.57K | 1.15M | 1.38M | 0 | 2.16M |
| Total Assets | 710.38M | 1.41B | 1.45B | 1.49B | 1.09B | 811.9M | 403.83M | 2.52M |
| Asset Turnover | 1.75x | 0.97x | 1.01x | 1.30x | 1.53x | 1.51x | - | - |
| Asset Growth % | -49.44% | -2.78% | -3.15% | 37.12% | 34.03% | 101.05% | 15901.2% | - |
| Total Current Liabilities | 106.56M | 160.75M | 233.59M | 263.79M | 220.94M | 277.49M | 1.53M | 2.77M |
| Accounts Payable | 16.65M | 36.01M | 73.01M | 115.49M | 85.72M | 67.09M | 1.53M | 0 |
| Days Payables Outstanding | 5.99 | 11.76 | 20.99 | 25.41 | 22.95 | 25.51 | - | - |
| Short-Term Debt | 3.64M | 4.09M | 7.96M | 12.09M | 0 | 0 | 0 | 2.68M |
| Deferred Revenue (Current) | 50.46M | 80.18M | 97.37M | 92.77M | 65.33M | 49.57M | 0 | 0 |
| Other Current Liabilities | 9.73M | 6.84M | 27.55M | 17.65M | 37.1M | 134.11M | 0 | 88.14K |
| Current Ratio | 3.60x | 3.39x | 2.46x | 2.44x | 2.95x | 1.68x | 0.06x | 0.13x |
| Quick Ratio | 3.60x | 3.39x | 2.46x | 2.44x | 2.95x | 1.68x | 0.06x | 0.13x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 10.4M | 59.1M | 64.47M | 73.52M | 58.69M | 74.85M | 17.08M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 3.21M | 0 |
| Capital Lease Obligations | 10.4M | 700.68K | 4.79M | 12.69M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 58.4M | 59.68M | 60.83M | 58.69M | 59.73M | 0 | 0 |
| Other Non-Current Liabilities | -7 | 0 | 0 | 0 | 0 | 15.12M | 13.87M | 0 |
| Total Liabilities | 116.96M | 219.85M | 298.06M | 337.32M | 279.63M | 352.34M | 18.61M | 2.77M |
| Total Debt | 14.04M | 4.8M | 12.74M | 24.78M | 0 | 0 | 3.21M | 2.68M |
| Net Debt | -293.58M | -247.73M | -192.26M | -149.36M | -240.69M | -224.78M | 3.13M | 2.32M |
| Debt / Equity | 0.02x | 0.00x | 0.01x | 0.02x | - | - | 0.01x | - |
| Debt / EBITDA | - | 0.09x | 0.34x | 0.15x | - | - | - | 3.47x |
| Net Debt / EBITDA | - | -4.41x | -5.06x | -0.92x | -1.41x | -1.14x | - | 3.00x |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | 593.42M | 1.19B | 1.15B | 1.15B | 808.59M | 459.55M | 385.22M | -245.7K |
| Equity Growth % | -49.93% | 3.32% | -0.67% | 42.83% | 75.95% | 19.3% | 156887.96% | - |
| Book Value per Share | 14.20 | 28.52 | 28.22 | 29.41 | 26.22 | 17.13 | 52.97 | -0.03 |
| Total Shareholders' Equity | 615.37M | 1.2B | 1.15B | 1.15B | 808.59M | 459.55M | 385.22M | -245.7K |
| Common Stock | 475.53M | 468.03M | 446.52M | 418.02M | 153.07M | 103.76M | 384.6M | 172.56K |
| Retained Earnings | 92.02M | 662.45M | 627.42M | 660.74M | 478.69M | 322.63M | 624.04K | -418.26K |
| Treasury Stock | -19.95M | -19.95M | -19.18M | -16.38M | 0 | 0 | 0 | 0 |
| Accumulated OCI | 46.96M | 67.67M | 62.52M | 56.92M | 48.84M | 33.16M | 0 | 0 |
| Minority Interest | -21.95M | -13.78M | -835.92K | 1.88M | 0 | 0 | 0 | 0 |
Asset impairment and contraction
As reported in recent financial statements, Scienjoy's total assets plummeted from $1.4 billion in 2025Q2 to $710.4 million by 2025Q4, a significant reduction that suggests a fundamental downsizing of the company's balance sheet footprint amidst ongoing operational challenges and persistent revenue contraction.
The rapid decline in total assets appears to be driven by the disappearance of substantial goodwill, which dropped from $183.1 million to zero in the most recent quarter. This suggests that management may have recognized significant impairments, reflecting a more cautious valuation of the company's historical acquisitions.
Based on the latest quarterly filings, Scienjoy maintains a cash position of $307.6 million, which, when paired with a current ratio of 3.60, indicates a substantial liquidity buffer that may protect the firm from immediate insolvency despite its ongoing operational losses.
While the liquidity position appears robust on the surface, investors should monitor the rate at which this cash is consumed to fund operating deficits. The high current ratio suggests that the company is not currently facing a liquidity crunch, though this capital remains largely idle rather than being deployed for growth.
According to the provided balance sheet data, total equity has experienced a sharp decline from $1.2 billion in 2025Q2 to $615.4 million in 2025Q4, primarily driven by the impact of accumulated losses on the company's retained earnings and the recent write-down of intangible assets.
The significant reduction in equity highlights the erosion of shareholder value resulting from the company's inability to achieve profitability. This trend warrants further investigation into whether additional impairments may be necessary if the core business continues to underperform against its historical carrying values.
As indicated by the 2025Q4 balance sheet, the total elimination of $183.1 million in goodwill suggests that previous acquisition-related valuations were likely unsustainable, potentially masking the true extent of the company's operational deterioration over the preceding several quarters.
The sudden removal of these intangible assets implies that the company's historical growth strategy may have been built on overly optimistic assumptions. Investors should be wary that the balance sheet may still contain other assets that could be subject to future downward revisions if market conditions remain unfavorable.
Quick answers to the most common questions about buying SJ stock.
As of 2025, Scienjoy Holding Corporation (SJ) had total assets of $710.4M including $383.2M in current assets.
Scienjoy Holding Corporation (SJ) carries total debt of $14.0M, offset by $316.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Scienjoy Holding Corporation (SJ) has total shareholders' equity (book value) of $615.4M ($14.20 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Scienjoy Holding Corporation (SJ) reported a current ratio of 3.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.